McMaster Perspective

  • Heart failure treatment: SGLT-2 inhibitors

    Heart failure treatment: SGLT-2 inhibitors

    Dr Harriette Van Spall, associate professor in the Division of Cardiology at McMaster University, scientist at the Population Health Research Institute, and cardiologist at Hamilton Health Sciences, answers questions about the role of SGLT-2 inhibitors in heart failure treatment.

  • Depression: Choosing pharmacologic treatments

    Depression: Choosing pharmacologic treatments

    Dr Zainab Samaan, associate professor in the Department of Psychiatry and Behavioral Neurosciences at McMaster University, offers an expert overview of the currently available pharmacologic treatments of depression.

  • Depression in the era of COVID-19

    Depression in the era of COVID-19

    Dr Zainab Samaan, associate professor in the Department of Psychiatry and Behavioral Neurosciences at McMaster University, talks about distinctive features of depression and available treatments.

  • Hypertension: The role of adherence in treatment

    Hypertension: The role of adherence in treatment

    Dr Giuseppe Mancia, former president of the International Society of Hypertension and the European Society of Hypertension, discusses the role of patients' adherence in antihypertensive treatment.

  • COVID-19: To treat or not to treat? June 18 update. Part 2

    COVID-19: To treat or not to treat? June 18 update. Part 2

    Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, talks about dexamethasone, estrogens, plasma, and other treatment options for COVID-19.

  • Hypertension: Highlights from the 2020 ISH guidelines

    Hypertension: Highlights from the 2020 ISH guidelines

    Dr Giuseppe Mancia, past president of the International Society of Hypertension and the European Society of Hypertension and author of over 1000 papers in peer-reviewed journals, offers a brief review of the new guidelines from the International Society of Hypertension.

  • COVID-19: To treat or not to treat? June 18 update. Part 1

    COVID-19: To treat or not to treat? June 18 update. Part 1

    Dr Jean-Louis Vincent, professor of intensive care medicine at Université libre de Bruxelles and past president of the World Federation of Societies of Intensive and Critical Care Medicine, discusses the evolution of the COVID-19 situation around the world.

  • Hypertension in the age of COVID-19

    Hypertension in the age of COVID-19

    Dr Giuseppe Mancia, professor emeritus at the University of Milano-Bicocca and past president of the International Society of Hypertension and the European Society of Hypertension, discusses the use of ACE inhibitors and ARBs in the context of COVID-19.

  • COVID-19: Optimal physical distancing, masks, and eye protection

    COVID-19: Optimal physical distancing, masks, and eye protection

    Dr Derek Chu, clinician scientist at McMaster University, discusses the just-published meta-analysis from The Lancet that reviews evidence for using physical distancing, facemasks, and eyewear to prevent COVID-19 spread.

  • COVID-19: To treat or not to treat? May 15 update

    COVID-19: To treat or not to treat? May 15 update

    Dr Mark Crowther, chair of the Department of Medicine at McMaster University and past president of the Anticoagulation Forum, offers an expert overview of our current understanding of thrombosis and anticoagulation in patients with COVID-19.

187 articles - page 8 of 19

We would love to hear from you

Comments, mistakes, suggestions?

We use cookies to ensure you get the best browsing experience on our website. Refer to our Cookies Information and Privacy Policy for more details.